FDA Clearance Tracker · P180046
Axonics Sacral Neuromodulation System
Last checked: Nov 20, 2026Latest source record: Nov 13, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Nov 13, 2019
Approved
Time to decision
342 days
Received Dec 6, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P180046
- Device name
- Axonics Sacral Neuromodulation System
- Applicant
- Boston Scientific Corporation
- Applicant location
- Marlborough, MA
- Received
- Dec 6, 2018
- Decided
- Nov 13, 2019
- Decision
- Approved
- Supplements
- 103 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Regulation
- 21 CFR 876.5270
FDA's approval statement
As written in FDA's record.
Approval for the Axonics Sacral Neuromodulation System. The device is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code EZW. The earliest in FDA's data is P970004, decided Sep 29, 1997.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Boston Scientific Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
K261153 · Decided Aug 26, 2026 · 140 days after receipt
Device type: Ureteroscope And Accessories, Flexible/Rigid (FGB) · GI, Urology & Nephrology
K261915 · Decided Aug 4, 2026 · 56 days after receipt
Device type: Endoscopic Access Overtube, Gastroenterology-Urology (FED) · GI, Urology & Nephrology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.